We recently published 10 Stocks Slump Amid Wall Street Cheer; 2 Hit Rock Bottom. Molina Healthcare, Inc. (NYSE:MOH) is one of the worst performers on Thursday. Molina Healthcare extended losses to a third straight session on Thursday, to be just 30-cents shy of its 52-week low, as investor sentiment was dragged by a dismal earnings performance and a 31-percent lower net income forecast for the full-year 2025. In an updated report, Molina Healthcare, Inc. (NYSE:MOH) said it now expects 2025 net profit to ...

Core Viewpoint - A lawsuit has been filed against Molina Healthcare, Inc. and certain senior executives for potential violations of federal securities laws, with claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [1][2]. Group 1: Lawsuit Details - Investors have until December 2, 2025, to request to lead the case, which is pending in the U.S. District Court for the Central District of California [2]. - The case is titled Hindlemann v. Molina Healthcare, Inc., et al., No. 25-cv-9461 [2]. Group 2: Company Background - Molina Healthcare is a health insurance company providing managed healthcare services to low-income individuals under Medicaid and Medicare programs [3]. - The company previously claimed a "solid" earnings growth profile heading into 2025 and stated it was monitoring utilization patterns to mitigate healthcare cost inflation [3]. Group 3: Financial Performance and Stock Impact - On July 7, 2025, Molina reported Q2 2025 adjusted earnings of approximately $5.50 per share, which was below prior expectations due to medical cost pressures across all business lines [4]. - The company cut its guidance for expected adjusted earnings per share by 10.2% to a range of $21.50 to $22.50 per share [4]. - Following further revelations on July 23, 2025, regarding a challenging medical cost trend environment, Molina's stock price fell by $32.03, or 16.8%, from $190.25 to $158.22 per share [4].

Molina Healthcare (NYSE: MOH ) is an upstart in the Health Insurance space. I last wrote about Molina in an article comparing them to United Healthcare ( UNH ) the old dog in the space.The author has an honours degree in economics and politics with a focus on economic development. With 36 years of experience in executive management he has extensive knowledge of insurance/reinsurance, Global and Asia Pacific markets, climate change and ESG. He invests in his personal capacity.Analyst’s Disclosure:I/we have a ...

Molina Healthcare (NYSE: MOH ) is an upstart in the Health Insurance space. I last wrote about Molina in an article comparing them to United Healthcare ( UNH ) the old dog in the space.The author has an honours degree in economics and politics with a focus on economic development. With 36 years of experience in executive management he has extensive knowledge of insurance/reinsurance, Global and Asia Pacific markets, climate change and ESG. He invests in his personal capacity.Analyst’s Disclosure:I/we have a ...

Core Insights - Molina Healthcare experienced a significant stock decline of over 17% following its quarterly earnings report, contrasting with a positive market trend where the S&P 500 gained 0.6% [1] Financial Performance - In Q3, Molina's total revenue reached nearly $11.5 billion, marking an 11% year-over-year increase, but net income fell sharply to $97 million ($1.84 per share) from $347 million in the previous year [2][3] - The company surpassed the average analyst revenue estimate of $10.94 billion but significantly missed the consensus for adjusted net income, which was projected at $3.91 per share [3] Business Segments - CEO Joseph Zubretsky indicated that approximately half of the company's underperformance was attributed to the marketplace business, while Medicaid maintained strong margins despite some pressure [3] Future Guidance - Molina revised its 2025 guidance, slightly increasing the revenue forecast to $44.5 billion but lowering the adjusted net profit estimate to $742 million, or about $14 per share, which still falls short of analyst expectations of just under $45.6 billion and $18.62 per share [4][6]

Core Insights - Las Vegas Sands experienced a significant stock increase of 12.4% after reporting better-than-expected revenue and adjusted earnings per share for Q3, attributed to recent investments in Macau and Singapore properties [5][9] - Molina Healthcare's stock fell 17.5% due to rising medical costs, particularly in government-sponsored plans, leading to a lowered annual profit forecast for the third time this year [10][9] Market Performance - Major U.S. equity indexes rose, with the S&P 500 gaining 0.6%, the Dow up 0.3%, and the Nasdaq increasing by 0.9%, driven by surging oil prices and a rebound in tech stocks [3] - Dow reported a narrower-than-expected loss despite missing net sales estimates, resulting in a 13% increase in its shares due to cost-cutting measures and new asset contributions [4] Sector Highlights - West Pharmaceutical Services saw a 10.9% increase in shares after surpassing earnings estimates and raising its full-year sales and profit outlook, driven by strong demand for components in GLP-1 treatments [6] - Oil prices surged following U.S. sanctions on Russia's largest oil companies, positively impacting exploration and production firms like APA Corp., which saw a 7.6% stock increase [7]

Core Viewpoint - Molina Healthcare, Inc. is facing a class action lawsuit for alleged violations of the Securities Exchange Act of 1934, with claims centered around undisclosed adverse financial conditions and misleading guidance during the class period from February 5, 2025, to July 23, 2025 [1][4]. Summary by Sections Class Action Details - The class action lawsuit is titled Hindlemann v. Molina Healthcare, Inc., and it allows investors who purchased Molina securities during the specified class period to seek appointment as lead plaintiff by December 2, 2025 [1][7]. - The lawsuit alleges that Molina Healthcare and its executives failed to disclose critical information regarding the company's financial health, particularly concerning medical cost trends and their impact on earnings guidance [4][5]. Financial Performance and Guidance - On July 7, 2025, Molina Healthcare reported adjusted earnings of approximately $5.50 per share, which was below prior expectations due to medical cost pressures across all business lines [5]. - The company cut its earnings guidance for fiscal year 2025 by 10.2% at the midpoint, citing a dislocation between premium rates and medical costs [5]. - On July 23, 2025, Molina reported a GAAP net income of $4.75 per diluted share for Q2 2025, an 8% decrease year-over-year, and revised its full-year adjusted earnings expectation to no less than $19.00 per diluted share [6]. Allegations of Misleading Information - The lawsuit claims that Molina Healthcare did not disclose material adverse facts about its medical cost trend assumptions and the dependency of its growth on reduced utilization of various health services [4][6]. - Following the negative earnings report and guidance cut, Molina's stock price fell nearly 17%, indicating a significant market reaction to the disclosed financial difficulties [6].

Core Insights - Molina Healthcare, Inc. (MOH) reported Q3 2025 adjusted EPS of $1.84, missing the Zacks Consensus Estimate of $3.97, and a 69.4% decline from the previous year [1][10] - Total revenues reached $11.5 billion, reflecting an 11% year-over-year increase and surpassing the consensus estimate by 5.3% [1][10] Financial Performance - Premium revenues amounted to $10.8 billion, an 11.8% increase year over year, exceeding the Zacks Consensus Estimate of $10.3 billion, driven by buyouts, rate hikes, and an expanding footprint [3] - Total operating expenses rose 14.9% year over year to $11.3 billion, higher than the model estimate of $10.5 billion, primarily due to increased medical care costs and general administrative expenses [5] - The consolidated medical care ratio (MCR) was 92.6%, up from 89.2% a year ago, and above the consensus mark of 90.3% [6][10] Membership and Income - Total membership increased by 0.5% year over year to approximately 5.6 million, although it fell short of the Zacks Consensus Estimate by 2% [4] - Adjusted net income plummeted 72% year over year to $97 million [6] Cash Flow and Guidance - Cash and cash equivalents at the end of Q3 were $4.2 billion, down from $4.7 billion at the end of 2024 [7] - Management revised premium revenue guidance to approximately $42.5 billion for 2025, indicating a 10% improvement from 2024, while adjusted EPS is now forecasted to be around $14, down from a previous estimate of at least $19 [9][11]

Accessibility StatementSkip Navigation On this news, Molina's stock price fell $6.97, or 2.9%, to close at $232.61 per share on July 7, 2025, on unusually heavy trading volume. Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Molina To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Molina between February 5, 2025 and July 23, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partn ...

Core Viewpoint - Molina Healthcare's stock plummeted over 20% following a significant earnings miss for Q3, attributed to rising medical expenses and a lowered guidance for Q4 [1][2]. Financial Performance - Molina's adjusted EPS for Q3 was $1.84, missing analyst expectations of $3.89 by more than 50% [2]. - The company projects Q4 adjusted earnings of $0.35, significantly below analysts' expectations of $2.42 [2]. Medical Care Ratio (MCR) - Molina's consolidated MCR for Q3 was 92.6%, up from 89.2% in the same quarter last year, indicating increased medical expenses impacting profitability [4]. - A 92.6% MCR means the company retained only 7.4 cents per dollar of premium revenue after covering medical expenses [5]. - The MCR for ACA plans was particularly high at 95.6%, exceeding both analyst predictions of 86% and Molina's own 73% from the previous year [6]. Industry Context - The MCR is a critical metric for healthcare providers, reflecting the balance between premium revenue and medical expenses [3]. - Rising medical costs and the structure of ACA plans have posed significant challenges for Molina, affecting its financial stability [5][6].